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ABSTRACT
Contrasting data exist on the effect of gender and menopause on the
susceptibility, development and liver damage progression in non-
alcoholic fatty liver disease (NAFLD). Our aim was to assess whether
menopause is associated with the severity of liver fibrosis in
individuals with NAFLD and to explore the issue of ovarian
senescence in experimental liver steatosis in zebrafish. In 244
females and age-matched males with biopsy-proven NAFLD, we
assessed anthropometric, biochemical and metabolic features,
including menopausal status (self-reported); liver biopsy was
scored according to ‘The Pathology Committee of the NASH
Clinical Research Network’. Young and old male and female
zebrafish were fed for 24 weeks with a high-calorie diet. Weekly
body mass index (BMI), histopathological examination and
quantitative real-time PCR analysis on genes involved in lipid
metabolism, inflammation and fibrosis were performed. In the entire
cohort, at multivariate logistic regression, male gender [odds ratio
(OR): 1.408, 95% confidence interval (95%CI): 0.779-2.542, P=0.25]
vs women at reproductive agewas not associated with F2-F4 fibrosis,
whereas a trend was observed for menopause (OR: 1.752, 95% CI:
0.956-3.208, P=0.06). In women, menopause (OR: 2.717, 95% CI:
1.020-7.237, P=0.04) was independently associated with F2-F4
fibrosis. Similarly, in overfed zebrafish, old female fish with failing
ovarian function [as demonstrated by extremely low circulating
estradiol levels (1.4± 0.1 pg/µl) and prevailing presence of atretic
follicles in the ovaries] developed massive steatosis and substantial
fibrosis (comparable with that occurring in males), whereas young
female fish developed less steatosis and were totally protected from
the development of fibrosis. Ovarian senescence significantly
increases the risk of fibrosis severity both in humans with NAFLD
and in zebrafish with experimental steatosis.
KEY WORDS: Fibrosis, Menopause, Non-alcoholic fatty liver
disease, Ovarian senescence, Zebrafish
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) affects about 20-30% of
the general population (Bedogni et al., 2005) and is a leading cause
of chronic liver disease worldwide (Marchesini et al., 2003; Petta
et al., 2009). A relevant proportion of individuals with NAFLD is at
risk of progression to cirrhosis and its complications (Petta and
Craxi, 2010; Petta et al., 2009), and there is a high rate of cancer and
cardiovascular events (Targher et al., 2008) in such individuals
compared with subjects without fatty liver.
In NAFLD individuals, a number of factors like obesity, insulin
resistance (IR) and necroinflammation (Argo et al., 2009; Bugianesi
et al., 2006; Petta et al., 2011b; van der Poorten et al., 2008) have been
reported to be involved in determining the severity of liver fibrosis
and its progression. In addition, new players in the pathogenesis of
liver damage in NAFLD are emerging, such as genetic background
(Dongiovanni et al., 2013), fructose consumption (Abdelmalek et al.,
2010) and hyperuricemia (Petta et al., 2011a).
Different lines of evidence indicate a higher risk of metabolic
disturbances among menopausal females (Lovejoy et al., 2008), and
accordingly, experimental studies show a protective anti-fibrogenic
and anti-steatogenic effect of estrogens (Chow et al., 2011; Hewitt
et al., 2004; Itagaki et al., 2005; Yasuda et al., 1999). Despite these
interesting data, only a few studies have investigated the impact of
gender and, in particular, of menopausal status on the severity of
liver disease in individuals with NAFLD. Browning et al. (2004)
report a higher prevalence of NAFLD in males with respect to
females, this effect being restricted to the Caucasian population
only, but not to Hispanic and African Americans. By contrast, some
epidemiological studies from Germany (Volzke et al., 2007), the
USA (Clark et al., 2002), Korea (Park et al., 2006) and Japan
(Hamaguchi et al., 2012) show that menopause increases the
prevalence and incidence of NAFLD. Similarly, other work
suggests that hormone replacement therapy (HRT) is protective
against NAFLD after menopause (McKenzie et al., 2006). Finally, a
recent study from the USA has identified an independent risk factor
for fibrosis severity in self-reported or age-presumed menopause
among a cohort of males and females with non-alcoholic
steatohepatitis (NASH) (Yang et al., 2014).
As an experimental model to test the relationship between
steatosis and the development of fibrosis from a gender perspective,
we chose zebrafish for its remarkable similarities with mammals in
lipid metabolism. As in humans, dietary lipids are delivered from
the intestine to the liver and from the liver to extra-hepatic tissues
(Asaoka et al., 2013; Holtta-Vuori et al., 2010). Recently, Oka et al.Received 19 January 2015; Accepted 8 July 2015
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(2010) have described a model of dietary-induced obesity in
zebrafish, which shares common pathophysiological features with
mammalian obesity.
The aims of our study were therefore to assess, in a large cohort of
individuals with histological diagnosis of NAFLD, whether
menopausal status is associated with the severity of liver fibrosis,
and to explore this same issue in an experimental model of liver
steatosis in zebrafish.
RESULTS
Human NAFLD
Clinical features and histology
The baseline characteristics of both reproductive-age and
menopausal women, as well as of their age-matched groups of
males are reported in Table 1. Women at reproductive age,
compared with age-matched males, had higher high-density
lipoprotein (HDL) cholesterol serum levels (P<0.001), whereas
no differences in other metabolic parameters and in histological
severity of liver disease were observed. Similarly, in menopausal
women, compared with age-matched males, there was a higher
prevalence of obesity, as well as higher total (P<0.001) and HDL
(P<0.001) cholesterol levels.
When comparing reproductive age versus menopausal women,
the latter had a higher prevalence of metabolic disturbances [higher
total cholesterol, P=0.02; higher homeostasis model assessment
(HOMA), P=0.05; type 2 diabetes, P=0.004; arterial hypertension,
P<0.001], whereas no significant differences were present in the
histological features.
Notably, 15 (9.6%) menopausal females were on HRT, all of
them for a period equal to or longer than 6 months. No difference
was observed in terms of metabolic variables by stratifying for HRT,
but there was a lower prevalence of arterial hypertension (20% vs
51.6%, P=0.02) (supplementary material Table S1), whereas
menopausal women on HRT compared with their counterparts not
on HRT had a lower prevalence of NASH (33.3% vs 70.3%,
P=0.009) and a trend towards a lower prevalence of F2-F4 fibrosis
(33.3% vs 60%, P=0.08).
Factors associated with significant liver fibrosis (F2-F4)
Supplementary material Table S2 shows variables linked to F2-F4
fibrosis in the entire cohort of males and females. Specifically, by
using women at reproductive age as reference, male gender [odds
ratio (OR): 1.408, 95% confidence interval (95% CI): 0.779-2.542,
P=0.25] was not independently associated with F2-F4 fibrosis,
whereas a non-significant trend was observed for menopausal status
in women (OR: 1.752, 95% CI: 0.956-3.208, P=0.06).
When considering females only, HDL (OR: 0.982, 95% CI:
0.964-1.000, P=0.04), menopause (OR: 2.717, 95% CI: 1.020-
7.237, P=0.04), and NASH (OR: 3.214, 95% CI: 1.743-5.926,
P<0.001) were independently linked to F2-F4 fibrosis (Table 2). To
strengthen the concept that the effect of menopausal status in
females was independent of age, we performed subgroup analyses
by comparing women at different reproductive stages matched for
age. Specifically, when comparing 20 fertile [mean age 48 years,
mean body mass index (BMI) 30 kg/m2] with 20 age-matched
menopausal (mean age 48 years, mean BMI 33 kg/m2) women, the
latter had a significantly higher prevalence of F2-F4 fibrosis (six out
of 20 vs 16 out of 20, P=0.001). When age was excluded from the
model, menopause and F2-F4 fibrosis remained independently
associated (OR: 2.934, 95% CI: 1.096-7.914, P=0.03).
Finally, when considering males only, the following variables
were independently linked to F2-F4 fibrosis: age (OR: 1.039, 95%
CI: 1.011-1.068, P=0.006), BMI (OR: 1.111, 95% CI: 1.029-1.200,
P=0.007) and NASH (OR: 4.458, 95% CI: 2.405-8.264, P<0.001).
Zebrafish NAFLD
Characterization of reproductive status
In order to study the effect of diet at different reproductive ages, we
used young and old zebrafish. To substantiate the reproductive age,
in particular the ovarian senescence in old female fish, we analyzed
the circulating levels of estradiol and performed histopathologic
evaluation of ovaries (Fig. 1).
As shown in Fig. 1A, circulating estradiol (E2) levels sharply
decreased from fertile young female fish (4 months old) (7.7±
0.94 pg/µl) to 18-month-old female fish (1.4±0.1 pg/µl)
(P=0.0006), with intermediate values in 13-month-old fish (2.1±
1.6 pg/µl) (4-month- vs 13-month-old fish P=0.0022) (Fig. 1A). E2
TRANSLATIONAL IMPACT
Clinical issue
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic
liver disease in western countries with a prevalence of 20-30% in the
overall population. It is characterised by a wide spectrum of clinical
manifestations, from simple steatosis to steatohepatitis (NASH), to
advanced fibrosis and cirrhosis, as well as by complications like
decompensation, variceal bleeding and hepatocellular carcinoma
(HCC). Different studies have demonstrated that non-alcoholic hepatic
steatosis is less common in women than in men, that anti-estrogenic
therapy increases the risk of non-alcoholic steatohepatitis and that the
prevalence of NAFLD is lower in women of reproductive age. The aim of
this study was to assess whether gender, age and menopause affect the
susceptibility to liver damage both in humans with NAFLD and in
zebrafish with experimental steatosis.
Results
In this study, the authors demonstrated that menopausal women have a
higher prevalence of metabolic disturbances [including higher total
cholesterol, higher homeostasis model assessment (HOMA) index – a
measure of insulin resistance, type 2 diabetes and arterial hypertension]
than women of reproductive age and that menopausal status increases
the risk of having stage F2-F4 hepatic fibrosis (defined as: F2 moderate
fibrosis, F3 severe fibrosis and F4 cirrhosis). The experimental data
obtained in the model of diet-induced obesity in zebrafish are extremely
similar to those found in humans, and include different susceptibilities to
liver fibrosis according to reproductive phases. Histopathological
examination of zebrafish liver showed that young female zebrafish are
protected from the development of fibrosis, whereas all the other groups
(young and oldmale fish, and old female fish) are not, thus reinforcing the
hypothesis of a protective effect of estrogens and of a role for ovarian
senescence in the development of hepatic fibrosis. Expression analysis
of genes in zebrafish liver that are involved in lipid metabolism,
inflammation and fibrosis showed a pattern reflecting that which leads
to steatosis and fibrosis in mice and humans, and supports the
hypothesis that simple overfeeding is able to induce liver steatosis and
fibrosis.
Implication and future directions
The data reported in this study call for attention to the reproductive status
of individuals with NAFDL and/or NASH, and suggests that this aspect
should not be overlooked in the management of such individuals.
Zebrafish data indicate that the model of diet-induced obesity, replicating
features of obesity and steatosis in humans, could be very useful to study
the long-term effects of excessive calorie intake on the development of
steatosis and fibrosis from a gender and age perspective. The ease of
the overfeeding protocol, the homogenous response of zebrafish to
overfeeding and the rapid development of steatosis and fibrosis in this
animal also make it a manageable tool for testing drugs or interventions
for the treatment of NAFLD.
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levels in both young and old male fish were significantly different
from those values found in young and old female fish (young female
vs young male fish: 7.7±0.94 pg/µl vs 4.5±2.15 pg/µl, P=0.0342;
old female vs old male fish: 1.4±0.1 pg/µl vs 4.2±1.8 pg/µl,
P=0.0013). E2 levels were not significantly different between
young and old male fish.
Histopathological analysis revealed a significant difference
between young and old females. Ovaries in young females
showed a compact, tightly organized structure, with a high
number of follicles in different stages of maturation (Fig. 1C,D).
Ovaries in old female fish showed a much looser structure, with
degeneration of ovarian tissue and presence of atretic follicles
(Fig. 1E,F). Quantification of follicles at different stages of
maturation (Fig. 1B; supplementary material Fig. S1) showed, in
young female fish, a significantly higher number of mature follicles
(i.e. stage 2 to 4) (young vs old female fish at stage 2, 3 and 4:
P=0.014, 0.004, 0.031, respectively) in comparison with that in old
female fish. Conversely, the percentages of stage 1 (P=0.008) and
atretic follicles (P=0.031) were significantly higher in old females
(Fig. 1B).
Table 1. Comparison between females, stratified according to menopausal status, and age-matched males with NAFLD
Women of reproductive
age (n=74)
Age-matched
men (n=74) P
Menopausal women
(n=170)
Age-matched men
(n=170) P
Mean age (years) 38.2±9.1 38.7±9.3 0.70 58.0±6.1* 57.4±7.3 0.40
Body mass index (kg/m2)
Mean (range) 29.6±4.8 (20-44) 29.2±4.9 (21-45) 0.59 29.6±5.4 (18-47) 29.0±4.3 (21-50) 0.23
BMI (%)
<25 kg/m2 16.3 10.8 16.5 11.8
≥25-<30 kg/m2 35.1 52.7 0.10 37.6 50.6 0.05
≥30 kg/m2 48.6 36.5 45.9 37.6
Waist circumference (cm) 98.8±10.5 102.6±11.9 0.10 100.2±14.5 102.1±15.8 0.38
Alanine aminotransferase (IU/l) 82.9±65.8 82.4±51.8 0.95 66.8±50.1 58.3±36.8 0.07
Cholesterol (mg/dl) 203.7±45.3 194.4±48.2 0.22 218.6±45.6* 194.0±44.2 <0.001
HDL cholesterol (mg/dl) 56.1±17.1 46.5±11.0 <0.001 58.0±18.5 43.7±12.4 <0.001
Triglycerides (mg/dl) 131.9±90.1 134.3±72.6 0.85 141.8±61.2 149.7±84.5 0.32
Blood glucose (mg/dl) 99.8±38.6 92.3±17.5 0.13 107.9±33.4 107.3±30.6 0.84
Insulin (µU/ml) 16.9±10.2 16.6±10.3 0.86 19.7±13.5 17.9±11.4 0.28
HOMA 4.02±2.20 3.79±2.82 0.58 4.89±3.56* 4.63±3.30 0.49
Type 2 diabetes 10 6 0.29 53* 60 0.42
Arterial hypertension 15 10 0.30 83* 75 0.50
Steatosis grade 1 vs 2 vs 3 26, 32, 16 28, 20, 26 0.07 77, 49, 44 81/55/34 0.44
Steatosis grade 1-2 vs 3 58, 16 48, 26 0.06 126/44 136, 34 0.19
Lobular inflammation 0 vs 1 vs 2
vs 3
8, 47, 17, 2 7, 50, 15, 2 0.96 23, 92, 49, 6 20, 93, 54, 3 0.69
Lobular inflammation 0-1 vs 2-3 55, 19 57, 17 0.70 115/55 113/57 0.81
Ballooning 0, 1, 2 14, 32, 28 16, 28, 30 0.74 53, 55, 62 63, 59, 48 0.10
NASH (yes, no) 20, 54 17, 57 0.56 56, 114 73/97 0.06
Stage of fibrosis 0, 1, 2, 3, 4 17, 22, 23, 5, 7 15, 23, 24, 10, 2 0.32 37, 35, 44, 35, 19 28, 42, 37, 34, 29 0.33
Stage of fibrosis 0-1 vs 2-4 39, 35 38, 36 0.86 72, 98 69, 101 0.74
Data are given as mean±standard deviation or as number of case. *P<0.05 vs women of reproductive age.
Table 2. Univariate and multivariate analysis of factors associated with significant liver fibrosis (F2-F4) in females with NAFLD
F0-F1 fibrosis
(n=111)
F2-F4 fibrosis
(n=133)
Univariate analysis
P-value
Multivariate analysis
OR (95% CI)
Multivariate analysis
P-value
Variance inflation
factor
Mean age* (years) 51.8±10.5 52.1±12.5 0.82 0.977 (0.940-1.015) 0.23 2.76
Mean body mass index
(kg/m2)
28.5±5.9 30.5±5.3 0.004 1.045 (0.987-1.106) 0.12 1.07
Waist circumference (cm) 100.1±13.5 99.6±13.3 0.81
Alanine aminotransferase
(IU/l)
56.9±35.6 84.1±65.6 0.001
Cholesterol (mg/dl) 217.2±45.8 211.5±46.0 0.33
HDL cholesterol (mg/dl) 60.7±20.2 54.7±15.6 0.009 0.982 (0.964-1.000) 0.04 1.19
Triglycerides (mg/dl) 129.3±62.5 146.7±77.0 0.05 1.001 (0.996-1.005) 0.78 1.20
Blood glucose (mg/dl) 102.8±34.0 107.8±36.1 0.27
Insulin (µU/ml) 14.7±9.2 21.7±13.8 <0.001
HOMA 3.76±2.53 5.34±3.57 <0.001
Type 2 diabetes 20 43 0.01 1.914 (0.965-3.794) 0.06 1.12
Arterial hypertension 42 56 0.54
Menopause 72 98 0.13 2.717 (1.020-7.237) 0.04 2.77
Steatosis grade 1 vs 2-3 64, 47 39, 94 <0.001
Lobular inflammation
0-1 vs 2-3
99, 12 71, 62 <0.001
Ballooning 0, 1, 2 42, 42, 27 25, 46, 62 <0.001
NASH (yes, no) 48, 63 25, 108 <0.001 3.214 (1.743-5.926) <0.001 1.05
Data are given as mean±standard deviation or as number of case. *Age forced into the model owing to the strong relation with menopause.
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Body mass index
As a result of overfeeding, the BMI was already significantly
increased after 3 weeks, in comparison with the baseline (P=0.04).
A significant increase in BMI was evident from week 6 onwards in
overfed zebrafish as compared with controls (P<0.05 at each time
point) (supplementary material Fig. S2A). All overfed zebrafish
(n=164) developed obesity after a median period of overfeeding of
16 weeks. Analysis of zebrafish BMI according to age and gender
revealed that the median increase in BMI was 23% in old animals
(both males and females), 26% in young males and 33% in young
females (supplementary material Fig. S2B).
Histopathological evaluation of zebrafish liver
Microscopic evaluation of haematoxylin and eosin staining (H&E)
of control and overfed zebrafish liver tissue revealed the presence of
hepatic steatosis in overfed zebrafish as early as 1 week after the
beginning of the overfeeding protocol (supplementary material
Fig. S3A). No changes were observed in the liver of control
animals throughout the study. To further evaluate whether lipids
accumulated in the liver, hepatic tissue was stained with Oil Red O.
In overfed zebrafish, most of the cell cytoplasm was occupied by
large fat vacuoles, as shown in Fig. 2A. A significant increase in Oil
Red O staining was observed in all overfed groups but young
females at week 1 compared with respective baseline fish (male
young: P=0.033; male old: P=0.009; female young: P=0.283;
female old: P=0.014) (supplementary material Fig. S3B). Periodic
acid–Schiff staining (PAS) was used to identify the presence of
glycogen. Control livers exhibited normal glycogen storage,
whereas overfed livers revealed low levels of glycogen confined
in the peripheral region of hepatocytes (supplementary material
Fig. S3A).
A significant enlargement of hepatocyte area was observed: the
increase in hepatocyte size was rapid, being already present in all
age groups 1 week after the beginning of overfeeding (P<0.001
compared with the respective baseline for each subgroup). A
significant increase in the area of the hepatocytes was observed in
all four groups, although young female zebrafish, despite
developing the largest BMI increase, had at all time points,
significantly lower steatosis than the other three groups (Fig. 2B).
Although hepatocyte area decreased after week 6, at week 24 it was
still significantly higher than at baseline in male (both old and
young) and old female groups (P<0.0001 for each intra-group and
inter-group comparison) but not in young female, in which it
decreased at week 24 to the level observed at week 1 (t0 vs t24:
P=0.725) (Fig. 2B). Similar to steatosis, triglyceride levels in the
liver significantly increased during the overfeeding period,
reaching their maximum at week 6 in all considered groups but
young males (male old and female old: P<0.0001 and female
young: P=0.0002 vs their corresponding baseline). In young males,
the highest triglyceride levels were observed at week 16 (week 16
vs baseline: P<0.001). Young females had significantly lower peak
levels of liver triglyceride as compared with other groups (vs old
males and old females at week 16: P<0.0001; vs young males at
week 6: P=0.0092) (Fig. 2C).
Liver fibrosis was assessed by using Sirius Red staining, which
detects collagen (Fig. 3A). A significant increase in the level of
Fig. 1. Definition of reproductive age in zebrafish. (A) Serum estradiol levels in female andmale zebrafish during ageing. Data are reported asmean±s.d. Final
sample number=12 per sex/age. (B) Application of the ovary maturation classification in the evaluation of the effects of ageing on zebrafish ovarian tissue (see
supplementary material Fig. S1 for details). Three sections from five fish per subgroup were analyzed. Datawere expressed asmean±s.d. H&E-stained (C,E) and
PAS-stained (D,F) sections of the ovaries of young (4 mpf) and old (18 mpf) female zebrafish. Atretic follicles (indicated by arrows) were mostly found in old
female fish with low to absent E2 levels. mpf, months post fertilization.
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fibrosis compared to that at baseline could be observed already at
week 6 in young males (P<0.0001) and in old females (P=0.038).
Fibrosis further increased at week 16 (young males: P<0.0001; old
males: P=0.0003; old females: P=0.011 all vs their baseline) and at
week 24 (young males: P<0.0001; old males: P<0.0001; old
females: P=0.004 all vs their respective baseline). At all time points
analyzed, young females did not show any increase in fibrosis as
compared with their basal level (Fig. 3B). At week 24, young
females had a significantly lower level of fibrosis as compared with
that of all other groups (P<0.001 vs young males, old males and old
females).
Deregulation of genes involved in lipid metabolism and liver damage
To investigate the mechanisms underlying the development and
progression of liver damage in obesity-associated conditions, we
analyzed the expression of marker genes involved in lipid
metabolism ( pparg, ppara and sreb1c), hepatic lipogenesis and
fatty acid oxidation (creb3l3), inflammation (il6) and fibrosis (tgfb)
(Fig. 4). Quantitative real-time PCR (RT-qPCR) analyses showed
increased transcript levels for pparg and srebp1c, and decreased
creb3l3 transcript levels at weeks 6 and 16 in all groups but young
females, in which the reverse occurred (Fig. 4A,B,D).
Upregulation of ppara was observed in all groups as compared
with controls. However, in young females, the levels of ppara
mRNA were significantly lower as compared with that of all the
other groups (Fig. 4C). Increased expression of the il6 transcript
was found in males and old females from week 6, and in old males
at week 16. In young females, il6 was downregulated at all time
points (Fig. 4E). tgfb showed an increased expression in older
animals from week 1, as compared with basal levels. In young
animals (both males and females), tgfb expression was mostly
downregulated (Fig. 4F).
DISCUSSION
In this study, which considered a large cohort of females and age-
matched males by using histological diagnosis of NAFLD, we
found that menopause is associated with a significantly higher risk
of relevant liver fibrosis (i.e. equal to or higher than F2). By
contrast, women at reproductive age are at significantly lower risk of
developing relevant liver fibrosis. The same negative effect of
ovarian senescence and the protective effect of fertile age were also
found in female zebrafish with experimental steatosis.
Fig. 2. Hepatic steatosis in overfed zebrafish. (A) Oil Red O staining of liver sections from young males, old males, young females and old female zebrafish at
baseline, and after 1 week of overfeeding. Scale bar: 20 µm. The percentage of the area stained by Oil Red O was quantified by using Image J (Schneider et al.,
2012) in three sections from five fish per subgroups (supplementary material Fig. S3B). (B) To compare the development of steatosis between different groups, we
measured, by using ImageJ (Schneider et al., 2012), the surface area of 30 randomly assigned hepatocytes in three sections from five different fish per subgroup,
which had been stained with H&E (Kuroda et al., 2012). Values are expressed asmeans±s.e.m. The group of young females was compared with each of the other
groups (*P<0.0001; **P<0.01). (C) Quantification of liver triglyceride in overfed zebrafish that had been grouped according to age and gender. Final sample
number=6 per subgroup. Values are expressed as means±s.e.m. (*P<0.0001 young females vs old males and old females; °P=0.0049 young females vs young
males; **P<0.0001, the group of young females was compared with each of the other groups).
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Epidemiological studies report a higher prevalence of NAFLD in
males compared with females, and such studies also indicate an
increase in NAFLD prevalence and incidence in menopausal
females in comparison with reproductive-age females (Chow et al.,
2011; Hewitt et al., 2004; Itagaki et al., 2005; Yasuda et al., 1999).
However, data on the impact of gender and of menopausal status on
liver disease severity are few and inconclusive. We observed that in
the entire cohort (males and females), childbearing age was
associated with a trend towards a lower prevalence of significant
(stage F2-F4) liver fibrosis, this effect being observed in
comparisons with menopausal females but not with the entire
cohort of males. Of note, this association between menopause and
increased fibrosis was maintained after adjustment for age, a strong
determinant of menopause and fibrosis progression; for metabolic
comorbidities associated with menopause, such as obesity and
diabetes; and for histological features of NASH. Taken together, our
data strongly add to the understanding of the effect of menopause on
liver fibrosis in NAFLD. A recent study from the USA (Yang et al.,
2014) on a cohort of 541 consecutive subjects (352 females) with
biopsy-proven NASH has also reported the protective effect of
being of reproductive age on fibrosis. Because two different cohorts,
one from Europe and one from the USA, gave similar results, a
meta-analytic pooling of the two cohorts would be useful to further
explore the clinical impact of menopause on liver damage in
NAFLD and to identify clinical subgroups at higher risk.
The more relevant clinical finding of our study lies in the fact that,
for the first time to our knowledge, we assessed the impact of
menopausal status on the severity of liver damage in females with
NAFLD. We clearly showed that menopause is associated with a
higher risk of significant liver fibrosis, which is independent of age
and of metabolic comorbidities. The strong association between
menopause and liver fibrosis, possibly related to the much stronger
surge of inflammatory activation associated with menopause, is in
line with data in chronic hepatitis C (Villa et al., 2011, 2012). These
data, if confirmed, could prompt a more careful management of
NAFLD pathogenic factors during the first phases of menopause to
reduce the progression of liver damage, also suggesting that there is
an opportunity to use HRT to delay liver damage progression. In
line with this, similar to other studies (McKenzie et al., 2006), we
reported lower levels of liver damage in menopausal females with
NAFLD that were undergoing HRT therapy compared with those
that were not.
Our clinical evidence is further supported by data obtained in a
model of overfed zebrafish. The first advantage of this model, in
Fig. 3. Assessment of hepatic fibrosis in overfed zebrafish. (A) Sirius Red staining of liver sections from young males, old males, young females and old
female zebrafish at baseline, and after 24 weeks of overfeeding. Scale bar: 30 µm. (B) Quantification of liver fibrosis by using computer-assisted digital image
analysis. Data are reported as collagen proportionate area (CPA) converted into a percentage. Three sections from five fish per subgroup were analyzed. Values
are expressed as means±s.d. *P<0.0001 for young females versus all the other groups.
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comparison with mice, is the very high occurrence of obesity and
steatosis (Buettner et al., 2007; Burcelin et al., 2002). Indeed, all
overfed fish developed obesity and fatty liver. Aside from this high
occurrence, the zebrafish model has another relevant advantage over
mice, with respect to the evaluation of fibrosis development
according to reproductive stages – the occurrence of ovarian
senescence in zebrafish is spontaneous, whereas in mice it has to
be induced through an ovariectomy (Gopalakrishnan et al., 2013).
The 18-month-old and older female zebrafish is a convincing
‘menopausal prototype’ because the very low circulating E2 levels
and ovarian histology (Fig. 1; supplementary material Fig. S1) are
indicators of the occurrence of spontaneous ovarian senescence. E2
levels were significantly lower in old versus young female zebrafish
(P=0.0006) and lower, but to a lesser extent, in 13-month-old
zebrafish (P=0.048), indicative of a progressive hormonal decline
similar to that observed in women when transitioning from
reproductive age to menopause (Villa et al., 2012). Furthermore,
in old versus young zebrafish, a significantly higher number of
immature and atretic follicles, characteristic of ovarian senescence,
were present. By contrast, in young fertile zebrafish, the number of
maturing follicles was significantly higher than that in older
zebrafish (Fig. 1; supplementary material Fig. S1). Female zebrafish
at 18 months of age and older can therefore be convincingly
considered to be in a menopause-like state.
With our model, we showed that old overfed female zebrafish
developed hepatic steatosis and fibrosis in amanner similar to overfed
males (both young and old). By contrast, young female fish, despite a
high increase in BMI, developed less steatosis and were completely
protected from the development of fibrosis. Gene expression analysis
supports the view that simple overfeeding is able to start a series of
events that lead first to liver steatosis and then to fibrosis, and that the
ovarian senescence increases the risk of fibrosis. Old overfed female
zebrafish exhibited a pattern of gene expression in the liver that is
associated with hepatic fat accumulation, similar to males.
Specifically, females showed an increase in pparg and srebp1c,
two genes that are known to be involved in activation and de novo
lipogenesis, as well as the hepatic synthesis of fatty acid (Hsu and
Huang, 2006; Tailleux et al., 2012; Yu et al., 2003), and a decrease in
creb3l3, which has a protective role with regards to the development
of steatosis (Zhang et al., 2012). Upregulation of tgfb expression in
old animals (both males and females), and of note of il6 expression in
old animals and youngmales (i.e. those showing the highest levels of
Fig. 4. RT-qPCR analysis for the expression of marker genes in the livers of overfed zebrafish. Genes involved in lipid metabolism (A-D), inflammation
(E) and fibrosis (F) in zebrafish. Samples from five fish per subgroup were analyzed. Gene expression was reported as the calibrated normalized relative quantity
(CNRQ) geometric mean±s.e.m. of each group expressed as log(2). Each value was normalized to the CNRQ geometric mean of the corresponding control.
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fibrosis both through histology and digital imaging evaluation) also
supports our hypothesis (Bayer et al., 1998; Collins et al., 2013; Park
et al., 2010). The data in zebrafish, together with the known lower
expression of estradiol receptor in the liver of individuals with NASH
(Erkan et al., 2013) and the inhibitory effect of estradiol on expression
of TGFB1, TNFA (Itagaki et al., 2005; Yasuda et al., 1999), IL6 and
IL1B (Kireev et al., 2010; Rogers and Eastell, 2001) also suggest a
protective effect of fertile status on the severity of liver damage in
NAFLD. The marked upregulation of hepatic TNFA and IL6 at the
time of early menopause, becoming non-significant in late
menopause, could explain the strong but selective association we
observed between liver fibrosis and early menopause.
A limit of our study lies in the lack of data, among the NAFLD
population, on serum estrogen levels that, instead of menopausal
status, could give a direct measure of the link between ovarian
reserve and both histological and metabolic disturbances, as already
observed for liver fibrosis in chronic hepatitis C (Villa et al., 2012),
and for cholesterol levels in other clinical settings (Persson et al.,
2012; Ramezani Tehrani et al., 2014).
In conclusion, this study on a large cohort of women and age-
matched men with histological diagnosis of NAFLD shows that
menopausal status increases the risk of fibrosis severity. These data
were supported and reinforced by our findings in overfed zebrafish
with experimental steatosis. These results, which need validation in
other NAFLD settings, suggest that a more intensive management
should be planned for females with NAFLD in pre- and early
menopause.
MATERIALS AND METHODS
Subjects
We analyzed data from 244 consecutive Italian women (meaning that they
presented within a certain time period and that none were excluded)
prospectively recruited at five referral centers from Palermo (n=86), Turin
(n=67), Milan (n=39), Rome (n=34) and Modena (n=18), and 244 center
age-matched males, all with a clinical and histological diagnosis of NAFLD.
Individuals with other causes of liver disease (alcoholic, viral, autoimmune,
hereditary hemochromatosis and α1-antitrypsin deﬁciency), with advanced
cirrhosis and/or hepatocellular carcinoma, and with current use of steatosis-
inducing drugs were excluded.
The study was performed in accordance with the principles of the
Helsinki Declaration, and with local and national laws. Approval was
obtained from the hospital Internal Review Boards and the Ethics
Committees (124/11 Men_Epid, prot.n.2420/CE), and informed consent
for the study was obtained from all controls and test subjects.
Clinical and laboratory assessment in human NAFLD
Clinical and anthropometric data were collected at the time of liver biopsy.
BMI was calculated on the basis of weight in kilograms and height in
meters. The diagnosis of arterial hypertension was based on the following
criteria – systolic blood pressure ≥135 mmHg and/or diastolic blood
pressure ≥85 mmHg (measured three times within 30 min, in the sitting
position and using a brachial sphygmomanometer), or use of blood-
pressure-lowering agents. The diagnosis of type 2 diabetes was based on the
revised criteria of the American Diabetes Association, using a value of
fasting blood glucose ≥126 mg/dl on at least two occasions (American
Diabetes Association, 2000). In individuals with a previous diagnosis of
type 2 diabetes, current therapy with insulin or oral hypoglycemic agents
was documented. Menopause was defined as no menstrual periods for 12
consecutive months; use of HRT was recorded.
A 12-h overnight fasting blood sample was drawn at the time of biopsy to
determine serum alanine aminotransferase, total cholesterol, HDL
cholesterol, triglycerides, and plasma glucose and insulin concentrations.
Insulin resistance was assessed by using HOMA with following equation
(Matthews et al., 1985) – insulin resistance (HOMA−IR)=fasting insulin
(μU/ml)×fasting glucose (mmol/l)/22.5 (Ikeda et al., 2001).
Assessment of histology in human NAFLD
Slides were coded and read at each clinical center by one expert pathologist,
who was unaware of the identity and history of individuals. A minimum
15-mm length of the biopsy specimen or the presence of at least 10
complete portal tracts was required (Colloredo et al., 2003). Steatosis was
assessed as the percentage of hepatocytes containing fat droplets (minimum
5%) and evaluated as a continuous variable. Kleiner classification (Kleiner
et al., 2005) was used to compute steatosis, ballooning and lobular
inflammation, and to stage fibrosis from 0 to 4. NASH was considered to
be present when steatosis, ballooning and lobular inﬂammation were
present.
Animals
Adult zebrafish were supplied by the Zebrafish International Research
Centre (Eugene, OR, USA), or bred in-house. The average age for the
‘young’ zebrafish group was 4 months, whereas that for the ‘old’ groups was
18 months (Shao et al., 2011). Animals were maintained in a ZebTec system
(Tecniplast, Buguggiate, Varese, Italy) at 28°C, 14 h:10 h light:dark cycle at
a density of 3-6 fish/l (Castranova et al., 2011). This density was chosen as it
does not affect fertility, size or viability of fish. All efforts were made to
minimize animal suffering and to reduce the number of animals used, in
accordance with the European Communities Council (2010/63/UE) and
with the requirements of the veterinary institutional review board of the
University of Modena and Reggio Emilia (2007/06_22).
Characterization of reproductive status
Determination of circulating estradiol levels
Zebrafish were anesthetized in ice-cold water, and blood was drawn from an
incision just between the anal fin and the caudal fin with a heparinized
pipette tip. Blood from two fish of the same sex and age was pooled as one
replicate (final sample number=12 per sex/age).
Serum was diluted with 200 μl double-distilled water, and the
concentration of estradiol was determined with EIA Estradiol Kit (Cayman
Chemical, Ann Arbor, MI, USA) following the manufacturer’s protocol.
Histopathological analysis of ovaries
To substantiate reproductive status, young and old female fish at enrolment
were euthanized and fixed by immersion for 24 h in neutral buffered 10%
formalin and paraffin-processed. Paraffin-embedded samples were cut into a
5-μm-thick section and stained by H&E and PAS staining.
Eggs are evidenced in ovaries in four maturation stages – stage 1
(primary growth stage), stage 2 (cortical alvelolus stage), stage 3
(vitellogenic stage) and stage 4 (mature phase). Menopausal ovaries are
characterized by atretic stage – the vitelline membrane structure starts to
disintegrate, the vitelline envelope breaks down and yolk reabsorption takes
place (supplementary material Fig. S1) (Aytekin and Yüce, 2008; Marlow
and Mullins, 2008).
Feeding zebrafish
Zebrafish were separated into two dietary groups (overfeeding and control
groups). Within the two dietary groups, zebrafish were divided into four
groups according to gender and age. Animals in the overfeeding group were
fed three times a day with artemia nauplii (11.6% lipid, 20.0%
carbohydrate, 61.6% protein, 6.8% ash; about 5013 cal g−1) (Zebrafish
Management, Winchester, UK) with 20 mg/fish, whereas fish in the control
group were fed twice a day with 5 mg/fish (Agh et al., 2008; Oka et al.,
2010). Overweight was defined as a 10% BMI increase, and obesity as a
20% increase in comparison with baseline BMI.
Histopathological analysis of zebrafish
Zebrafish were euthanized after anesthesia with 0.1 mg/ml tricaine (Sigma-
AldrichS.R.L.,Milan, Italy) (baseline and after 1, 6, 16 and24 weeks of diet),
and cryo-embedded inOCT(Miles Inc., Elkhart, USA) or fixed by immersion
for 24 h in neutral buffered 10% formalin and paraffin-processed. Frozen 5-
μm cryostat sections were stained with 0.5% Oil Red O (BDH Laboratory
Supplies, Dorset, UK) in propylene glycol and counterstained with Carazzi’s
haematoxylin (Sigma-Aldrich S.R.L., Milan, Italy).
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Paraffin-embedded samples were cut into 5 μm-thick sections and stained
by using H&E, Sirius Red or PAS staining.
0.1% Sirius Red (Chroma-Gesellschaft, Munster, Germany) in pyric acid
was applied for 50 min without haematoxylin counterstaining. Samples were
observed by using light microscopy Nikon Eclipse 80i (Nikon Instruments
Spa,CampiBisenzio, Florence, Italy) and acquiredwith aNikonDs-Fi2 digital
color camera (Nikon Instruments Spa, Campi Bisenzio, Florence, Italy).
Quantification of liver steatosis and fibrosis in zebrafish
Liver steatosis was quantified by measuring the area of hepatocytes using
the National Institutes of Health ImageJ software (http://rsbweb.nih.gov/)
(Kuroda et al., 2012; Schneider et al., 2012). Liver fibrosis was evaluated by
using computer-assisted digital image analysis of histological sections
stained with Sirius Red; hepatic collagen content was expressed as collagen
proportionate area (CPA) converted into a percentage (Calvaruso et al.,
2009). The collagen proportionate area was measured by using Zeiss
Axiovision image analysis software (rel 4.8) (Zeiss, Germany).
Triglyceride quantification in Zebrafish
Triacylglycerol levels in the liver were determined using Triglyceride
Quantification Kit (Biovision, Milpitas, CA, USA), according to
manufacturer’s protocol. Triglyceride levels were normalized to the
protein level in the liver. The protein levels in the liver were determined
using a colorimetric Protein Quantitation Kit (Euroclone, Milan, Italy)
according to manufacturer’s protocol.
RNA extraction and RT-qPCR in zebrafish
Total RNA was extracted from liver samples that had been frozen in liquid
nitrogen by using Nucleo Spin miRNA kit (Macherey-Nagel, Duren,
Germany) following the manufacturer’s protocol. cDNA synthesis was
performed using iScript Reverse Transcription Supermix (Bio-Rad
Laboratories, Hercules, CA, USA). RT-qPCR was performed on cDNA
samples using LightCycler 480 SYBR Green I Master Mix (Roche
Diagnostics, Indianapolis, IN, USA) and a Light Cycler 480 Real Time PCR
system (Roche Diagnostics, Indianapolis, IN, USA). The primer-sets can be
found in supplementary material Table S3. The mRNA expression was
normalized to that of gapdh, ef1a and actb mRNA using qBASEplus 2.4
(Hellemans et al., 2007). Datawere normalized on the corresponding control
and reported as log(2) mean±s.e.m. of biological replicates.
Statistics
Continuous variables were summarized as mean±standard deviation, and
categorical variables as frequency and percentage. The Student’s t-test and the
chi-square test, as well as ANOVA and Holm-Sidak tests were used when
appropriate (GraphPad Prism Software, San Diego, CA, USA). Multiple
logistic regression models were used to assess the factors that were
independently associated with significant fibrosis in the entire cohort, and
in males and females considered separately. In the models, the dependent
variable was fibrosis, coded as 0=not significant (F0-F1), and 1=significant
(F2-F4). Variables associated with the dependent variable on simple logistic
regression (probability threshold, P<0.10) were included in multiple logistic
regression. Age andmenopausewere also included in themodels ifP>0.10 on
simple regression because of their biological plausibility. To avoid the effect
of co-linearity, HOMA score, blood glucose, insulin levels and diabetes, as
well as waist circumference and BMI, or total and HDL cholesterol, or NASH
and steatosis, ballooning and lobular inflammation, were not included in the
same multivariate model. Regression analysis was performed using PROC
LOGISTIC, PROC REG, and subroutines in SAS (SAS Institute Inc., 1992).
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Supplemental figure 1. Developmental stages of the oocytes. Stage 1, perinucleolar 
oocytes. The oocytes size was small and ooplasm lacks granular structure. Stage 2, 
cortical alveolar oocytes. The vitelline envelope (zona radiata) begin to form. Stage 3, 
vitellogenic oocyte. The oocyte increased in size; the granular structures in ooplasm 
were larger and the nucleus was irregular in the shape. Stage 4, mature oocyte. The 
nucleus could not be observed due to the granular structures that filled up the entire 
cytoplas. Atretic stage. Oocyte and the vitelline membrane structure started to 
disintegrate.  
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Supplemental figure 2. Evaluation of BMI, length and food consumption in 
Zebrafish overfed with Artemia nauplii. (A) BMI (g/cm2) in overfed zebrafish 
(n=164) compared with control zebrafish (n=59). Values are expressed as means ± 
SEM. BMI constantly increased during the first 16 weeks of the dietary protocol 
reaching its maximum at week 16. From week 17 to 24 BMI reached a plateau. (B) 
Mean BMI in overfed zebrafish grouped according to age and gender (young males 
n=39, old males n=43, young females n=39 and old females=43). BMI strongly 
increased in the first weeks of overfeeding but it was almost stable after week 16 in 
all groups but old females. In this group BMI started to decrease after week 16 
reaching, by the end of the observation period, a much lower BMI than at baseline 
although no relevant change was observed throughout the study in the length of 
animals (C). (C) Length in cm of overfed zebrafish grouped accordingly with age and 
gender. Data were expressed as mean ± SEM (B) The percentage of eaten Artemia 
was measured by counting the number of Artemia in the feeding tank, before and 
after feeding as previously described (Oka et al.2010) and calculated on the total 
amount of given Artemia. 
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Supplemental figure 3. Hepatic steatosis in overfed zebrafish. (A) Representative 
H&E, and PAS staining of liver sections from controls (left) and overfed fish after 1 
week of treatment (right). Both controls and treated animals were old male fish. Size 
bar 20 mm. (B) Quantitation of Oil red O stained area in liver sections from young 
males, old males, young females and old females zebrafish at baseline and after 1 
week of overfeeding. The positive areas were measured with Image J (Schneider et 
al., 2012) and normalized on the total area of the section. The analysis has been 
carried out in three sections from 5 fish per subgroups. (* male young: p=0.033; ** male 
old: p=0.009; ° female young: p=0.283; °° female old: p=0.014; vs. respective 
baseline).
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Supplemental Table 1. Characteristics of menopausal females with non-alcoholic fatty liver disease according 
to hormonal replacement therapy. 
Menopausal Women 
No HRT 
(n=155) 
Menopausal Women 
on HRT 
(n=15) 
P value 
Mean Age – yrs 57.9 ± 6.2 58.5 ± 5.6 0.73 
Mean Body Mass Index – Kg/m2 29.7 ± 5.6 28.6 ± 3.9 0.49 
Alanine Aminotransferase – IU/L) 66.4 ± 49.3 72.2 ± 59.2 0.67 
Cholesterol –  mg/Dl 217.8 ± 45.0 227.8 ± 52.4 0.43 
HDL Cholesterol –  mg/Dl 58.4 ±19.0 54.0 ±10.6 0.40 
Triglycerides – mg/Dl 139.7 ± 61.2 165.0 ± 57.4 0.13 
Blood Glucose –  mg/Dl 108.4 ± 34.2 102.7 ± 23.1 0.54 
Insulin – µU/Ml 19.5 ± 13.7 17.4 ± 7.7 0.63 
HOMA 4.96 ± 3.67 4.05 ± 1.84 0.37 
Type 2 Diabetes 50 3 0.41 
Arterial Hypertension 80 3 0.02 
Steatosis Grade 1 vs. 2/3 69/86 8/7 0.71 
Lobular Inflammation 0/1 vs. 2/3 103/52 12/3 0.36 
NASH 109 5 0.009 
F2-F4 Fibrosis 93 5 0.08 
Data are given as mean ± standard deviation or as number of case. 
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Supplemental Table 2. Univariate and multivariate analysis of factors associated with significant liver fibrosis (F2-F4) in the entire cohort 
of female and age-matched male patients with non-alcoholic fatty liver disease. 
F0-F1 Fibrosis 
(n=218) 
F2-F4 Fibrosis 
(n=270) 
Univariate 
Analysis (P) 
Multivariate Analysis 
OR (95% CI)       
Multivariate 
Analysis (P) 
Male gender 107 137 .71 
Mean Age – yrs 50.8 ± 10.8 52.7 ± 12.3 .07 1.018 (0.998-1.039) .07 
Mean Body Mass Index – Kg/m2 28.1 ± 4.4 30.3 ± 5.0 <.001 1.069 (1.022-1.119) .004 
Waist Circumference- cm 99.0± 11.5 102.6± 15.5 .02 
Alanine Aminotransferase – IU/L) 60.4 ± 37.7 75.3 ± 57.1 .001 
Cholesterol –  mg/Dl 210.0 ± 44.4 199.3 ± 48.0 .01 
HDL Cholesterol –  mg/Dl 54.0 ±18.0 48.5 ±15.0 <.001 0.980 (0.966-0.994) .004 
Triglycerides – mg/Dl 134.7 ± 67.2 147.7 ± 82.7 .06 1.000 (0.997-1.003) .87 
Blood Glucose –  mg/Dl 100.1 ± 28.5 107.3 ± 34.0 .01 
Insulin – µU/Ml 13.8 ± 7.9 21.5 ± 13.2 <.001 
HOMA 3.55 ± 2.25 5.26 ± 3.63 <.001 
Type 2 Diabetes 38 91 <.001 1.833 (1.111-3.024) .01 
Arterial Hypertension 73 110 .14 
Male Gender/Menopause 
              Male Gender  vs. fertile women 
              Menopause 
179/39 235/35 .13 1.559 (0.902-2.694) 
1.408 (0.779-2.542) 
1.752 (0.956-3.208) 
.11 
.25 
.06 
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Steatosis Grade 1 vs. 2/3 110/108 102/168 .005 
Lobular Inflammation 0/1 vs. 2/3 186/32 154/116 <.001 
Ballooning 0/1/2 94/71/53 52/104/114 <.001 
NASH 109/109 57/213 <.001 3.799 (2.477-5.826) <.001 
Data are given as mean ± standard deviation or as number of case. 
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Supplemental Table 3 - Primers used for zebrafish qRT-PCR. Creb3l3 primers were designed 
in our laboratory by means of Primer3. 
Gene Forward Primer Reverse Primer Reference 
pparg 5’- CCTGTCCGGGAAGACCAGCG-3’ 5’-GTGCTCGTGGAGCGGCATGT-3’ Her et al.2011 
srebp1c 5’-CAGAGGGTGGGCATGCTGGC-3’ 5’-ATGTGACGGTGGTGCCGCTG-3’ Her et al. 2011 
ppara 5’-CTGCGGGACATCTCTCAGTC-3’ 5’-ACCGTAAACACCTGACGACG-3’ Her et al.2011 
creb3l3 5’-GCCACTCTGTCCGAATCTCA-3’ 5’-TGACTGAGGTGGGTTTCTGC-3’ 
il6 5’-TCAACTTCTCCAGCGTGATG-3’ 5’-TCTTTCCCTCTTTTCCTCCTG-3’ Varela et al. 2012 
tgfb 5’-GCACGGATAAGTTCCTCTTCAC-3’ 5’-CGAAAGTCAATGTAAAGCTTGC-3’ Liu et al. 2012 
gapdh 5’-TTCTCACAAACGAGGACACAA-3’ 5’-CAAGGTCAATGAATGGGTCA-3’ Oka et al.2010 
ef1a 5’-GTGCTGTGCTGATTGTTGCT-3’ 5’-TGTATGCGCTGACTTCCTTG-3’ Choi et al.2010 
actb 5’-ATTGCTGACAGGATGCAGAAG-3’ 5’-GATGGTCCAGACTCATCGTACTC-3’ Chu et al. 2012 
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